Certainty Of Stroke Symptom Onset Study "COSSO"

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

Intravenous tissue plasminogen activator (IV t-PA) is the only proven treatment of hyperacute cerebral infarction. The outcome of this treatment highly depends on the time from symptom onset to the administration of thrombolytic agent. Last known normal time is widely used as the standard to determine the symptom onset. These stroke symptoms are usually caused by a sudden decrease in cerebral blood flow related...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 August 2013.

1 Aug 2013 11 Aug 2013 1 Jun 2014 1 Aug 2014 1 Aug 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts